The results revealed that Gli1 expression in the highly aggressive (including histological differentiation, portal vein tumorous thrombogenesis, lymph node invasion and TNM stage) HCC group was significantly higher than that in the less aggressive HCC group. This evidence concerns the gene GLI1 and hepatocellular carcinoma.